AAAAAA
Results:
1-18
|
Results: 18
Authors:
GOLD JE
OSBAND ME
Citation: Je. Gold et Me. Osband, AUTOLYMPHOCYTE THERAPY - 1 - IN-VIVO TUMOR-SPECIFIC ADOPTIVE CELLULARTHERAPY OF MURINE MELANOMA AND CARCINOMA USING EX-VIVO ACTIVATED MEMORY T-LYMPHOCYTES (VOL 30, PG 1871, 1994), European journal of cancer, 34(6), 1998, pp. 946-946
Authors:
GOLD JE
OSBAND ME
Citation: Je. Gold et Me. Osband, AUTOLYMPHOCYTE THERAPY - II - DEPENDENCE OF IN-VIVO ANTITUMOR SPECIFICITY AND LONG-TERM IMMUNITY AGAINST MURINE MELANOMA AND CARCINOMA ON EX-VIVO ACTIVATED DONOR MEMORY T-CELLS (VOL 71, PG 325, 1994), Clinical immunology and immunopathology (Print), 87(3), 1998, pp. 314-314
Authors:
GOLD JE
ZACHARY DT
OSBAND ME
Citation: Je. Gold et al., ADOPTIVELY TRANSFERRED EX-VIVO ACTIVATED MEMORY T-CELLS WITH CYCLOPHOSPHAMIDE - EFFECTIVE TUMOR-SPECIFIC CHEMOIMMUNOTHERAPY OF ADVANCED METASTIC MURINE MELANOMA AND CARCINOMA (VOL 73, PG 115, 1994), Clinical immunology and immunopathology (Print), 87(3), 1998, pp. 314-314
Authors:
GOLD JE
MASTERS TR
OSBAND ME
Citation: Je. Gold et al., AUTOLYMPHOCYTE THERAPY - III - EFFECTIVE ADJUVANT ADOPTIVE CELLULAR THERAPY WITH IN-VIVO ANTITUMOR SPECIFICITY AGAINST MURINE MELANOMA AND CARCINOMA USING EX-VIVO-ACTIVATED MEMORY T-LYMPHOCYTES (VOL 59, PG 279, 1995), The Journal of surgical research, 74(2), 1998, pp. 196-196
Authors:
GOLD JE
ROSS SD
KRELLENSTEIN DJ
LAROSA F
MALAMUD SC
OSBAND ME
Citation: Je. Gold et al., ADOPTIVE TRANSFER OF EX-VIVO ACTIVATED MEMORY T-CELLS WITH OR WITHOUTCYCLOPHOSPHAMIDE FOR ADVANCED METASTATIC MELANOMA - RESULTS IN 36 PATIENTS, European journal of cancer, 31A(5), 1995, pp. 698-708
Authors:
GOLD JE
ZACHARY DT
OSBAND ME
Citation: Je. Gold et al., ADOPTIVELY TRANSFERRED EX-VIVO ACTIVATED MEMORY T-CELLS WITH CYCLOPHOSPHAMIDE - EFFECTIVE TUMOR-SPECIFIC CHEMOIMMUNOTHERAPY OF ADVANCED METASTATIC MURINE MELANOMA AND CARCINOMA (VOL 73, PG 115, 1994), Clinical immunology and immunopathology, 76(1), 1995, pp. 105-105
Authors:
GOLD JE
MASTERS TR
OSBAND ME
Citation: Je. Gold et al., AUTOLYMPHOCYTE THERAPY .3. EFFECTIVE ADJUVANT ADOPTIVE CELLULAR THERAPY WITH IN-VIVO ANTITUMOR SPECIFICITY AGAINST MURINE MELANOMA AND CARCINOMA USING EX-VIVO-ACTIVATED MEMORY T-LYMPHOCYTES, The Journal of surgical research, 59(2), 1995, pp. 279-286
Authors:
GOLD JE
MATERS TR
BLOOM ND
SHAFIR MK
KLEIN MJ
KENAN S
OSBAND ME
Citation: Je. Gold et al., EX-VIVO ACTIVATED MEMORY T-LYMPHOCYTES AS ADOPTIVE CELLULAR THERAPY OF HUMAN SOFT-TISSUE SARCOMA TARGETS WITH POTENTIATION BY CIS-DIAMMINEDICHLOROPLATINUM(II), Journal of surgical oncology, 58(4), 1995, pp. 212-221
Authors:
GOLD JE
ZACHARY DT
OSBAND ME
Citation: Je. Gold et al., ADOPTIVE TRANSFER OF EX VIVO-ACTIVATED MEMORY T-CELL SUBSETS WITH CYCLOPHOSPHAMIDE PROVIDES EFFECTIVE TUMOR-SPECIFIC CHEMOIMMUNOTHERAPY OF ADVANCED METASTATIC MURINE MELANOMA AND CARCINOMA, International journal of cancer, 61(4), 1995, pp. 580-586
Authors:
GOLD JE
MASTERS TR
BABBITT B
FINE EM
WEBER HN
UNGER PD
LEVENTHAL I
ZIPPE CD
OSBAND ME
Citation: Je. Gold et al., EX-VIVO ACTIVATED MEMORY T-LYMPHOCYTES AS ADOPTIVE CELLULAR THERAPY OF HUMAN RENAL-CELL TUMOR TARGETS WITH POTENTIATION BY CIS-DIAMMINEDICHLOROPLATINUM(II), British Journal of Urology, 76(1), 1995, pp. 115-122
Authors:
KRANE RJ
ROSS SD
BABBITT B
LAVIN PT
MARTIN J
GOODWIN J
CAPLAN B
ZHANG J
OSBAND ME
Citation: Rj. Krane et al., THE SCIENTIFIC AND CLINICAL-RESULTS OF EX-VIVO ACTIVATED T-CELLS FOR METASTATIC RENAL-CELL CARCINOMA IN OVER 500 HUMAN PATIENTS, Cell transplantation, 3, 1994, pp. 190000051-190000051
Authors:
GOLD JE
OSBAND ME
Citation: Je. Gold et Me. Osband, AUTOLYMPHOCYTE THERAPY .1. IN-VIVO TUMOR-SPECIFIC ADOPTIVE CELLULAR THERAPY OF MURINE MELANOMA AND CARCINOMA USING EX-VIVO ACTIVATED MEMORYT-LYMPHOCYTES, European journal of cancer, 30A(12), 1994, pp. 1871-1882
Authors:
GOLD JE
OSBAND ME
KRANE RJ
Citation: Je. Gold et al., ADOPTIVE CELLULAR THERAPY OF UROLOGICAL NEOPLASTIC DISEASE, Cancer treatment reviews, 20(2), 1994, pp. 173-190
Authors:
GOLD JE
ZACHARY DT
OSBAND ME
Citation: Je. Gold et al., ADOPTIVELY TRANSFERRED EX-VIVO ACTIVATED MEMORY T-CELLS WITH CYCLOPHOSPHAMIDE - EFFECTIVE TUMOR-SPECIFIC CHEMOIMMUNOTHERAPY OF ADVANCED METASTATIC MURINE MELANOMA AND CARCINOMA, Clinical immunology and immunopathology, 73(1), 1994, pp. 115-122
Authors:
GOLD JE
OSBAND ME
Citation: Je. Gold et Me. Osband, AUTOLYMPHOCYTE THERAPY .2. DEPENDENCE OF IN-VIVO ANTITUMOR SPECIFICITY AND LONG-TERM IMMUNITY AGAINST MURINE MELANOMA AND CARCINOMA ON EX-VIVO ACTIVATED DONOR MEMORY T-CELLS, Clinical immunology and immunopathology, 71(3), 1994, pp. 325-332
Authors:
GOLD JE
BLEIWEISS IJ
GOLDFARB AB
BAUER JJ
GELERNT IM
SCHWARTZ ME
REINER MA
MILLER CM
WEISS MF
BROWER ST
MASTERS TR
OSBAND ME
Citation: Je. Gold et al., ADOPTIVE CELLULAR THERAPY OF HUMAN BREAST AND COLORECTAL TUMOR TARGETS USING EX-VIVO ACTIVATED MEMORY T-LYMPHOCYTES WITH POTENTIATION BY CIS-DIAMMINEDICHLOROPLATINUM(II), Journal of surgical oncology, 55(4), 1994, pp. 222-228
Authors:
GOLD JE
MALAMUD SC
LAROSA F
OSBAND ME
Citation: Je. Gold et al., ADOPTIVE CHEMOIMMUNOTHERAPY USING EX-VIVO ACTIVATED MEMORY T-CELLS AND CYCLOPHOSPHAMIDE - TUMOR LYSIS SYNDROME OF A METASTATIC SOFT-TISSUE SARCOMA, American journal of hematology, 44(1), 1993, pp. 42-47
Authors:
ROSS SD
LAVIN PT
MARTIN J
MIESOWICZ F
OSBAND ME
Citation: Sd. Ross et al., A STATISTICAL-MODEL TO PREDICT OUTCOME IN PATIENTS WITH METASTATIC RENAL-CELL CANCER (RCC) TREATED WITH AUTOLYMPHOCYTE THERAPY (ALT), The Journal of immunology, 150(8), 1993, pp. 217-217
Risultati:
1-18
|